Paul Tudor Jones Accelerate Diagnostics, Inc Transaction History

Tudor Investment Corp Et Al

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$1.4 - $5.15 $87,371 - $321,401	62,408 Added 79.26%	141,142 $203,000
Q4 2021 Feb 14, 2022	BUY	$4.27 - $6.97 $198,465 - $323,958	46,479 Added 144.1%	78,734 $411,000
Q3 2021 Nov 15, 2021	SELL	$5.31 - $8.25 $69,380 - $107,794	-13,066 Reduced 28.83%	32,255 $188,000
Q2 2021 Aug 16, 2021	BUY	$6.81 - $9.23 $63,407 - $85,940	9,311 Added 25.86%	45,321 $365,000
Q1 2021 May 17, 2021	SELL	$7.99 - $15.0 $645,615 - $1.21 Million	-80,803 Reduced 69.17%	36,010 $300,000
Q4 2020 Feb 16, 2021	BUY	$7.04 - $11.7 $344,952 - $573,288	48,999 Added 72.25%	116,813 $885,000
Q3 2020 Nov 16, 2020	BUY	$9.98 - $18.04 $486,944 - $880,207	48,792 Added 256.5%	67,814 $723,000
Q2 2020 Aug 14, 2020	BUY	$7.49 - $15.16 $142,474 - $288,373	19,022 New	19,022 $288,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.